We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
-8.11%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
AUM
$33.6M
AUM Growth
-$4.65M
Cap. Flow
+$277K
Cap. Flow %
0.82%
Top 10 Hldgs %
81.84%
Holding
30
New
7
Increased
Reduced
7
Closed
6

Sector Composition

Rank Sector Weight
1 Energy 23.95%
2 Healthcare 23.64%
3 Technology 7.32%
4 Materials 3.39%
5 Real Estate 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPZ
1
DELISTED
Williams Partners L.P.
WPZ
$6.93M 20.59%
172,732
VEA icon
2
Vanguard FTSE Developed Markets ETF
VEA
$238B
$3.41M 10.15%
82,592
-8,483
-9% -$346K
VOO icon
3
Vanguard S&P 500 ETF
VOO
$1.03T
$3.04M 9.04%
13,695
-1,472
-10% -$324K
VOE icon
4
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$3M 8.92%
29,172
-3,136
-10% -$321K
VWO icon
5
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$2.63M 7.81%
64,329
-6,643
-9% -$269K
TXN icon
6
Texas Instruments
TXN
$253B
$2.46M 7.32%
32,000
SYRE icon
7
Spyre Therapeutics
SYRE
$9.18B
$2.02M 6.01%
20,997
BPTH
8
DELISTED
Bio-Path Holdings Inc
BPTH
$1.46M 4.33%
958
VRDN icon
9
Viridian Therapeutics
VRDN
$2.59B
$1.36M 4.05%
7,031
APEN
10
DELISTED
Apollo Endosurgery, Inc.
APEN
$1.22M 3.62%
154,301
-18,198
-11% -$148K
XOM icon
11
ExxonMobil
XOM
$657B
$1.13M 3.36%
+14,000
New +$1.15M
GMO
12
DELISTED
General Moly, Inc.
GMO
$1.08M 3.21%
2,922,831
VDE icon
13
Vanguard Energy ETF
VDE
$10.4B
$908K 2.7%
10,260
-1,055
-9% -$97.3K
VNQ icon
14
Vanguard Real Estate ETF
VNQ
$38.6B
$765K 2.27%
9,189
-639
-7% -$53.3K
LXRX icon
15
Lexicon Pharmaceuticals
LXRX
$1.05B
$587K 1.74%
35,714
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
$487K 1.45%
+17,800
New +$530K
JNCE
17
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$428K 1.27%
30,488
PLXP
18
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$385K 1.14%
+62,673
New +$459K
PK icon
19
Park Hotels & Resorts
PK
$2.99B
$258K 0.77%
9,587
MON
20
DELISTED
Monsanto Co
MON
$61K 0.18%
+515
New +$60.1K
DISCK
21
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$7K 0.02%
+290
New +$7.65K
JNJ icon
22
Johnson & Johnson
JNJ
$629B
$6K 0.02%
+47
New +$6K
POR icon
23
Portland General Electric
POR
$5.74B
$5K 0.01%
118
WBD icon
24
Warner Bros
WBD
$69.3B
$3K 0.01%
+115
New +$3.11K
FISV
25
Fiserv Inc
FISV
$27.4B
-3,200
Closed -$184K

Similar funds

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q2 2017 Portfolio in Review

As of Q2 2017, University of Texas/Texas AM Investment Management Co (UTIMCO) held 30 positions worth $33.6M, down 12% from $38.3M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q2 2017 filing shows 7 new, 7 reduced and 6 closed positions. Its largest new stake was ExxonMobil: 14,000 shares worth $1.13M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $346K.

By sector, the portfolio is most concentrated in Energy at 24% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q2 2017 buy was ExxonMobil: 14,000 shares worth $1.13M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q2 2017 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $346K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Fiserv Inc in Q2 2017, selling an estimated $184K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 82% of its $33.6M portfolio in Q2 2017.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 7 new positions and closed 6 in Q2 2017.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value fell 12% quarter-over-quarter to $33.6M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2017, filed 3 Aug 2017.